Anti-nausea drug for stomach cancer chemotherapy
Part of Cancer clinical trials.
This study tests an anti-nausea drug (nano-crystalline megestrol acetate) to see if it helps prevent nausea and vomiting caused by chemotherapy in people with stomach cancer. If you are starting your first chemotherapy, this may help you feel better during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to give informed consent.
- You must have stomach (gastric) cancer that is advanced, recurrent, or has spread, and is not able to be removed with surgery.
- You should not have had chemotherapy before (prior bladder or non-cancer treatments are okay).
- Your doctor plans to treat you with a type of immunotherapy (PD-1 inhibitor) plus a chemotherapy regimen called CAPOX.
- Your general health must be good, with normal blood counts, liver, kidney, and heart function.
- If you are at risk of pregnancy, you must use effective contraception during the trial and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new anti-nausea drug (HR20013) in patients receiving chemotherapy that often causes nausea and vomiting. It aims to see how well it works in real-world conditions, including for patients with liver problems.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
This study tests a new form of the drug megestrol (a medicine that helps with nausea and vomiting) for people receiving their first chemotherapy. It aims to see if it works better than the standard care to prevent the nausea and vomiting that often happens after chemo.
This study tests a stronger form of a drug called megestrol acetate (used to boost appetite and help with weight loss) combined with standard cancer treatment for advanced stomach or esophageal cancer. It aims to see if it can help you feel better and maintain your strength during treatment.
This study tests whether megestrol acetate (a hormone-like drug) can help prevent nausea and vomiting caused by strong chemotherapy drugs. It is designed for people with lung cancer who are about to start chemotherapy.
This trial tests a new form of a drug (nano-megestrol acetate) to help people with advanced pancreatic cancer who are losing weight and have poor appetite. It aims to see if it can improve cachexia, a condition of severe weight loss and muscle wasting.
Hear when a new Chemotherapy-Induced Nausea and Vomiting (CINV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.